Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
COR
AddedFeb 15, 2024
UpdatedJun 18, 2026
COR

COR

Series A

Science-driven platform for optimizing lifestyle through personalized health data insights.

HQ
San Francisco, CA, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to empower individuals through science-based self-knowledge, COR offers a platform designed to optimize lifestyle choices via personalized health data insights. The company's core product, the COR One, is an FDA-registered medical-grade device that allows users to measure chronic and acute inflammation using just a single drop of blood. By providing precise data on how various lifestyle practices impact the body, COR aims to help users make informed decisions to improve their overall health and well-being.

Notable affiliated people and investors include experts in medical technology and health sciences, although specific names are not disclosed. Key achievements for COR include the development and market introduction of the COR One device, which has been highly rated by users for its accuracy and ease of use. The platform's ability to offer actionable health insights has made a significant impact on how individuals approach personal health management, positioning COR as a leader in the personalized health data industry.

COR - Similar Companies

Coranet Solutions logo

Coranet Solutions

Cora logo

Cora

cora.life

Proactive Diagnostics logo

Proactive Diagnostics

pro-dx.com

Corinnova logo

Corinnova

corinnova.com

CoraVie Medical logo

CoraVie Medical

coraviemedical.com

Empericus logo

Empericus

CoreFount logo

CoreFount

RestoreHealth logo

RestoreHealth

restorehealth.com

InsideTracker logo

InsideTracker

insidetracker.com

Incora Health logo

Incora Health

incorahealth.com

Pnoē logo

Pnoē

pnoe.com

Corra Health logo

Corra Health

corra.health

Correlia Biosystems logo

Correlia Biosystems

Coro Health logo

Coro Health

corohealth.com

Wellcore logo

Wellcore

teamwellcore.com

COR - Quick Facts

Who are COR's competitors?

Companies similar to COR include Coranet Solutions, Cora, Proactive Diagnostics and Corinnova.

When was COR founded?

COR was founded in 2014.

Where is COR's headquarters located?

COR's headquarters is located in San Francisco, CA, US.

When was COR's last funding round?

COR's most recent funding round was for $12M (USD) in March 2022.

How much has COR raised to-date?

As of Mar 21, 2022, COR has raised a total of $14.4M (USD).

How many employees does COR have?

COR has 11 employees as of Feb 4, 2024.

COR - Classification

Industry
  • Hardware
Ownership
  • Private
  • Venture Capital
Technology
  • Analytics
  • HealthTech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Transactional
Customer
  • Consumers
Main Product
  • Health Data
  • Inflammation Tracking
Tags
  • Data
  • Healthtech
NAICS
  • 610000Educational Services
  • 611000Educational Services
SIC
  • 8200Educational Services
  • 8290Schools And Educational Services, Not Elsewhere Classified